Immuron (IMRN) Interest Expenses (2016 - 2025)
Immuron (IMRN) posted Interest Expenses of -$4678.4 for Q2 2025, down 324.6% on a QoQ basis from $2083.0 in Q3 2024, and up 6.3% year-over-year from -$4401.2 in Q2 2024.
Analysis
Immuron (IMRN) Interest Expenses (2016 - 2025) Analysis & Trends
Immuron has reported Interest Expenses for 10 years, with the latest figure at -$4678.4 in Q2 2025.
- On a quarterly basis, Interest Expenses rose 6.3% year-over-year to -$4678.4 in Q2 2025; TTM through Jun 2025 was $55570.3, a 6.74% decrease from a year earlier, with the FY2026 full-year figure at -$14712.0, down 20039.63% from the prior year.
- Interest Expenses was -$4678.4 for Q2 2025 at Immuron, down from $2083.0 in the prior quarter.
- The five-year high for Interest Expenses was $63158.4 in Q4 2023, with the low at -$14105.9 in Q2 2021.
- Average Interest Expenses over 5 years is $5368.0, with a median of $176.38 recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses surged 21228.69% in 2023, then tumbled 543.07% in 2024.
- Over 5 years, Interest Expenses stood at $56.64 in 2021, then jumped by 422.78% to $296.12 in 2022, then jumped by 21228.69% to $63158.4 in 2023, then tumbled by 96.7% to $2083.0 in 2024, then plunged by 324.6% to -$4678.4 in 2025.
- The last three Interest Expenses figures came in at -$4678.4 (Q2 2025), $2083.0 (Q3 2024), and -$4992.8 (Q2 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 673.00 Mn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 247.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 11.00 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | -1.00 Mn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Immuron | 10.28 Mn | 1.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -4,678.36 |
| Sep 9, 2024 | 2,082.99 |
| Jun 30, 2024 | -4,992.77 |
| Dec 31, 2023 | 63,158.45 |
| Jun 30, 2023 | 1,126.86 |
| Dec 31, 2022 | 296.12 |
| Dec 31, 2021 | 56.64 |
| Jun 30, 2021 | -14,105.87 |
| Dec 31, 2020 | -69.81 |
| Jun 30, 2020 | -28,354.81 |
| Dec 31, 2019 | -44.33 |
| Dec 31, 2018 | -39.00 |
| Dec 31, 2017 | -5,793.94 |
| Dec 31, 2016 | -9,939.69 |
| Jun 30, 2016 | -255,073.54 |